Andrew Tomkins1,2, Ryan George3, Merav Kliner4. 1. Manchester University Hospitals NHS Foundation Trust, The Hathersage Centre, Manchester M13 9WL, UK. 2. The Northern Integrated Contraception, Sexual Health & HIV Service, Manchester, UK. 3. Manchester University NHS Foundation Trust, Manchester, UK. 4. Public Health England North West, Manchester, UK.
Abstract
AIMS:: Sexualised drug taking is increasingly reported on national and international levels. We aim to review existing evidence of the relationship between recreational drug use (RDU) and sexual intercourse among men who have sex with men (MSM). METHODS: : We reviewed published abstracts and full articles identified from Cochrane, MEDLINE and Embase databases from November 2010 to 2017. We included any existing studies investigating RDU in MSM and at least one of the following: high-risk sexual practices, sexually transmitted infections (STIs) or barriers to accessing specialist support. RESULTS: : In total, 112 studies were included. Of them, 38 studies specifically reported the prevalence of chemsex-related drug use. Links with sexualised drug taking and high-risk sexual practices including condomless sex and group sex were reported by several studies. Recreational drug use in the sexual setting appears linked to the acquisition of STIs, including hepatitis C, syphilis and gonorrhoea. Reports of adverse mental health outcomes are increasingly described, with several studies documenting chemsex-related inpatient admission. A paucity of research addressing barriers to those accessing specialist drug support services was identified. CONCLUSION: : This review demonstrates the complex interplay between recreational drug use, high-risk sexual practices and STIs. It identifies the description of adverse mental health outcomes in the chemsex setting, thus highlighting the need for a multidisciplinary approach across specialties in the management of those adversely affected. Finally, it illuminates the need for future research into perceived barriers of those who require access to support services to ensure timely and comprehensive support provision.
AIMS:: Sexualised drug taking is increasingly reported on national and international levels. We aim to review existing evidence of the relationship between recreational drug use (RDU) and sexual intercourse among men who have sex with men (MSM). METHODS: : We reviewed published abstracts and full articles identified from Cochrane, MEDLINE and Embase databases from November 2010 to 2017. We included any existing studies investigating RDU in MSM and at least one of the following: high-risk sexual practices, sexually transmitted infections (STIs) or barriers to accessing specialist support. RESULTS: : In total, 112 studies were included. Of them, 38 studies specifically reported the prevalence of chemsex-related drug use. Links with sexualised drug taking and high-risk sexual practices including condomless sex and group sex were reported by several studies. Recreational drug use in the sexual setting appears linked to the acquisition of STIs, including hepatitis C, syphilis and gonorrhoea. Reports of adverse mental health outcomes are increasingly described, with several studies documenting chemsex-related inpatient admission. A paucity of research addressing barriers to those accessing specialist drug support services was identified. CONCLUSION: : This review demonstrates the complex interplay between recreational drug use, high-risk sexual practices and STIs. It identifies the description of adverse mental health outcomes in the chemsex setting, thus highlighting the need for a multidisciplinary approach across specialties in the management of those adversely affected. Finally, it illuminates the need for future research into perceived barriers of those who require access to support services to ensure timely and comprehensive support provision.
Entities:
Keywords:
genito-urinary; health protection; inequalities; public health; sexual health; sexually transmitted diseases
Authors: Lindsay Shaw; Lu Wang; Zishan Cui; Ashleigh J Rich; Heather L Armstrong; Nathan J Lachowsky; Paul Sereda; Kiffer G Card; Gbolahan Olarewaju; David Moore; Robert Hogg; Eric Abella Roth Journal: J Sex Res Date: 2019-08-28
Authors: Tyrel J Starks; Gabriel Robles; Stephen C Bosco; Kendell M Doyle; Trey V Dellucci Journal: Drug Alcohol Depend Date: 2019-05-23 Impact factor: 4.492
Authors: Natalie M Leblanc; Hugh F Crean; Typhanye P Dyer; Chen Zhang; Rodman Turpin; Nanhua Zhang; Martez D R Smith; James McMahon; LaRon Nelson Journal: Arch Sex Behav Date: 2021-04-26
Authors: Sean P Colyer; David M Moore; Zishan Cui; Julia Zhu; Heather L Armstrong; Matthew Taylor; Joshua Edward; Terry Howard; Chad Dickie; Gbolahan Olarewaju; Julio S G Montaner; Robert S Hogg; Eric A Roth; Nathan J Lachowsky Journal: Subst Use Misuse Date: 2020-10-15 Impact factor: 2.164
Authors: Nadia Hanum; Valentina Cambiano; Janey Sewell; Alison J Rodger; Nneka Nwokolo; David Asboe; Richard Gilson; Amanda Clarke; Ada R Miltz; Simon Collins; Valerie Delpech; Sara Croxford; Andrew N Phillips; Fiona C Lampe Journal: PLoS Med Date: 2021-06-18 Impact factor: 11.069